Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (3): 1-6.doi: 10.6040/j.issn.1671-7554.0.2018.1233

   

Effect of cisplatin on IL-6 expression in tumor mesenchymal stem cells and underlying mechanism of p38MAPK pathway

ZHANG Zhihui1, LIU Yanguo1, XIAO Fengqi1, MA Daoxin2, WANG Xiuwen1   

  1. 1.Department of Medical Oncology;
    2. Department of Hematology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2022-09-27

PDF (PC)

97

Abstract: Objective To investigate the effect of cisplatin(CDDP)on interleukin(IL)-6 expression in tumor mesenchymal stem cells(MSCs)and explore its possible mechanisms. Methods Lewis lung carcinoma(LLC)cells or MSCs were treated with CDDP, and their IL gene expression was detected by polymerase chain reaction array(PCR Array)and further verified by quantitative real-time polymerase chain reaction(qRT-PCR)and enzyme-linked immunosorbent assay(ELISA). After CDDP treatment, the activation of p38MAPK pathway in MSCs was analyzed by Western blotting. CDDP activated p38MAPK pathway was inhibited by the specific inhibitor, and IL-6 expression in MSCs was measured by ELISA. Results CDDP treatment showed no significant effect on the expression of IL-6 in LLC cells(P>0.05). However, IL gene expression was changed in MSCs treated with CDDP for 24 h, and IL-6 expression was increased most significantly. Further studies confirmed the increase of IL-6 mRNA and protein in MSCs after CDDP treatment for 3 h, 6 h and 24 h(P<0.05). Higher expressions of p38 and pp38 were detected in MSCs after CDDP treatment. Moreover, the ratio of pp38/p38 was significantly increased. After the p38MAPK pathway was inhibited by SB203580, the up-regulation of IL-6 caused by CDDP was partially reversed. Conclusion CDDP has no significant effect on IL-6 expression in LLC cells, but it significantly up-regulates the expression of IL-6 in MSCs. CDDP treatment activates the p38MAPK pathway in MSCs, and inhibiting this pathway resultes in down-regulation of IL-6. These results indicate that CDDP might regulate the expression of IL-6 in MSCs via the p38MAPK pathway.

Key words: Lung cancer, Cisplatin, Interleukin-6, Mesenchymal stem cells, p38MAPK pathway

CLC Number: 

  • R734.2
[1] Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
[2] 王善容, 丁月云, 朱宗平, 等. SPECT/CT融合骨显像诊断肺癌单发骨转移的价值[J]. 山东大学学报(医学版), 2018, 56(2):41-46. WANG Shanrong, DING Yueyun, ZHU Zongping, et al. Validity of SPECT/CT bone fusing imaging in the diagnosis of single bone metastasis of lung cancer[J]. Journal of Shandong University(Health Science), 2018, 56(2):41-46.
[3] Rossi A, Di Maio M. Platinum-based chemotherapy in advanced non-small-cell lung cancer:optimal number of treatment cycles[J]. Expert Rev Anticancer Ther, 2016, 16(6):653-660.
[4] 费成明, 常春康. 骨髓间充质干细胞介导恶性血液病耐药的研究进展[J]. 中华血液学杂志, 2018, 39(8):697-700. FEI Chengming, CHANG Chunkang. Bone marrow mesenchymal stromal cells mediated drug resistance in hematological malignancies[J]. Chinese Journal of Hematology, 2018, 39(8):697-700.
[5] Sun Y. Tumor microenvironment and cancer therapy resistance[J]. Cancer Lett, 2016, 380(1):205-215.
[6] Hui LL, Chen Y. Tumor microenvironment:Sanctuary of the devil[J]. Cancer Lett, 2015, 368(1):7-13.
[7] Melzer C, Yang YY, Hass R. Interaction of MSC with tumor cells[J]. Cell Commun Signal, 2016, 14(1):20. doi:10.1186/s12964-016-0143-0.
[8] Kraakman MJ, Kammoun HL, Allen TL, et al. Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance[J]. Cell Metab, 2015, 21(3):403-416.
[9] Alspach E, Flanagan KC, Luo XM, et al. p38MAPK plays a crucial role in stromal-mediated tumorigenesis[J]. Cancer Discov, 2014, 4(6):716-729.
[10] Gupta J, del Barco Barrantes I, Igea A, et al. Dual function of p38α MAPK in colon cancer:suppression of colitis-associated tumor initiation but requirement for cancer cell survival[J]. Cancer Cell, 2014, 25(4):484-500.
[11] Ling WF, Zhang JM, Yuan ZR, et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment[J]. Cancer Res, 2014, 74(5):1576-1587.
[12] Ren GW, Zhang LY, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide[J]. Cell Stem Cell, 2008, 2(2):141-150.
[13] Zimmermann S, Dziadziuszko R, Peters S. Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases[J]. Cancer Treat Rev, 2014, 40(6):716-722.
[14] Wu T, Dai Y. Tumor microenvironment and therapeutic response[J]. Cancer Lett, 2017, 387:61-68. doi:10.1016/j.canlet.2016.01.043.
[15] Chang Q, Daly L, Bromberg J. The IL-6 feed-forward loop:a driver of tumorigenesis[J]. Semin Immunol, 2014, 26(1):48-53.
[16] Nguyen DP, Li JY, Tewari AK. Inflammation and prostate cancer:the role of interleukin 6(IL-6)[J]. BJU Int, 2014, 113(6):986-992.
[17] Yao X, Huang JQ, Zhong HH, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers[J]. Pharmacol Ther, 2014, 141(2):125-139.
[18] Rossi JF, Lu ZY, Jourdan M, et al. Interleukin-6 as a therapeutic target[J]. Clin Cancer Res, 2015, 21(6):1248-1257.
[19] Davies R, Choy E. Clinical experience of IL-6 blockade in rheumatic diseases - implications on IL-6 biology and disease pathogenesis[J]. Semin Immunol, 2014, 26(1):97-104.
[20] Inoue N, Shimizu M, Tsunoda S, et al. Cytokine profile in adult-onset Still's disease:Comparison with systemic juvenile idiopathic arthritis[J]. Clin Immunol, 2016, 169:8-13. doi:10.1016/j.clim.2016.05.010.
[21] Melzer C, von der Ohe J, Hass R. Concise review:crosstalk of mesenchymal Stroma/Stem-like cells with cancer cells provides therapeutic potential[J]. Stem Cells, 2018, 36(7):951-968.
[22] Jones BE, Maerz MD, Buckner JH. IL-6:a cytokine at the crossroads of autoimmunity[J]. Curr Opin Immunol, 2018, 55:9-14. doi:10.1016/j.coi.2018.09.002.
[23] Jiang XY, Zhu XS, Liu N, et al. Diallyl trisulfide inhibits growth of NCI-H460 in Vitro and in Vivo, and ameliorates cisplatin-induced oxidative injury in the treatment of lung carcinoma in xenograft mice[J]. Int J Biol Sci, 2017, 13(2):167-178.
[24] Cuadrado A, Lafarga V, Cheung PC, et al. A new p38 MAP kinase-regulated transcriptional coactivator that stimulates p53-dependent apoptosis[J]. EMBO J, 2007, 26(8):2115-2126.
[25] Park GH, Park JH, Eo HJ, et al. The induction of activating transcription factor 3(ATF3)contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells[J]. BMC Complement Altern Med, 2014, 14:487. doi:10.1186/1472-6882-14-487.
[1] HAN Jing, JIA Chunling. Effects of periodontal basic therapy on postoperative pneumonia in patients with lung cancer before thoracic surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 113-118.
[2] GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49.
[3] QIN Jing, YANG Fei, CHEN Qian, XIA Handai, LIU Yanguo, WANG Xiuwen. A network meta-analysis of first-line treatment options for patients with advanced driver-gene wild-type and PD-L1 negative non-squamous non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 74-82.
[4] WANG Fuli, SUN Yinping, QIN Jie, RONG Jiansheng. Efficacy of DC-CIK cells combined with EGFR-TKI for 35 elderly patients with advanced EGFR-mutant lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 110-117.
[5] CHEN Zhaobo, FANG Min, XUE Haoran, LIU Chunyan. Deubiquitinase USP35 promotes the cells migration and invasion of non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 30-37.
[6] Jinming YU,Weiwei YAN,Dawei CHEN. New practice of radio-immunotherapy for lung cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 1-8.
[7] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1-6.
[8] ZHANG Yu, TANG Xing, MA Haitao, JIANG Wei. Value of indocyanine green fluorescence in thoracoscopic segmentectomy [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 38-42.
[9] ZHANG Xiqin, ZHU Shouhui, LIU Ning, WANG Yu, CHEN Jiazhen, HU Xudong. Clinical observation of PEG-rhG-CSF in preventing neutropenia in 80 patients with small cell lung cancer treated with concurrent chemoradiotherapy [J]. Journal of Shandong University (Health Sciences), 2020, 58(12): 43-46.
[10] LIU Xiaojing, XIA Xiyan, XIAO Ke, CHEN Wendan, ZHUANG Xuewei. Expression and clinical significance of exosomal long non-coding RNA OGFRP1 in 84 cases of non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 71-75.
[11] JIANG Yunfeng, DONG Xiaopeng, ZHAO Xiaogang. Combinatorial anti-PD-1 and endostatin therapeutic efficacy in Lewis lung cancer mice [J]. Journal of Shandong University (Health Sciences), 2018, 56(9): 11-16.
[12] WANG Bo, XUE Jiang, LIU Aihong, ZHAI Ruirui, WANG Yibiao. Rapamycin improved pulmonary artery hypertension via modulating the phenotypes of macrophages [J]. Journal of Shandong University (Health Sciences), 2018, 56(4): 51-57.
[13] HUANG Ping, ZHANG Kun, LI Fang, HUANG Guobao, YAN Bing,XIAO Dongjie, WANG Yunshan, LIU Hua. Comparative study on biological characteristics of mesenchymal stem cells from human umbilical cord and adipose [J]. Journal of Shandong University (Health Sciences), 2018, 56(3): 72-78.
[14] . Expert consensus on laboratory diagnosis of lung cancer [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 9-17.
[15] PAN Shiyang. Research advances in markers for the evaluation of lung cancer efficacy [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 31-39.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd